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DNA damage responses have been proposed as a gatekeeper to block tumorigenesis. We identify unexpected
mechanisms whereby ATM-mediated pathway interacts with NFkB inflammatory cascades, leading to upregulation of
integrin-abb3 on chemoresistant tumor cells. The integrin-abb3 is responsible for impeding tumor-specific immune
responses, linking chemoresistant niche with tumor immune evasion.
DNA damage checkpoint machineries
serve as a gatekeeper to keep cellular and
genetic integrity at steady-state. The
activation of DNA damage repairing
systems is frequently detected in pre-
cancerous and early tumor lesion, leading
to cell cycle arrest and apoptosis by p53-
dependent mechanisms.
1 In addition of
their direct actions to cell-intrinsic DNA
replication stress, DNA damage pathways
are responsible for inducing NKG2D
ligands on stressed cells, and activate
innate immune lymphocytes such as NK
cells and cdT cells to eliminate cells in
which accumulation of excessive genetic
damage may lead to oncogene activation
and transformation.
2 Moreover, the activa-
tion of DNA damage signals causes
proinflammatory cytokine secretion from
senescent tumor cells, further amplifying
antitumor innate immune responses
against transformed cells.
3,4 Thus, DNA
damage responses have critical functions in
maintaining cellular and genetic home-
ostasis by coordinately regulating genetic
and environmental sensing systems.
However, continuous activation of DNA
damage signals, which is frequently
occurred during tumor progression, may
contribute to genomic instability and
selective pressure to trigger p53 mutation,
leading to disruption of cell cycle arrest
and apoptosis. Thus, oncogene-induced
activation of DNA damage signals may
mediate diverse array of biological con-
sequences, which is dependent on distinct
sets of signals and their downstream
mediators delivered by various micro-
environment.
Recent evidences have unveiled the role
of tumor cells in the regulation of the
biologic properties of stromal cells,
endothelial cells, and host immunity in
local microenvironments, leading to fur-
ther tumor progression and a worse
prognosis.
5,6 Therefore, the acquisition of
anticancer drug resistance may render
tumor cells with the ability to modulate
their microenvironments in a paracrine
fashion, further enhancing survival signals
and the progression of tumors. However,
the molecular mechanisms regulating
interplay between tumor cells and immune
cells to create chemoresistant microenvir-
onments remain largely obscure.
We recently found some unexpected
aspects of DNA damage signals on anti-
cancer drug resistance of tumor cells. The
tumor cells acquired resistance to various
chemotherapeutic drugs exhibit constitu-
tive activation of sets of DNA damage
signals, ATM and chk-2. The constitutive
activation of ATM-mediated activation of
DNA damage pathways is indispensable
for triggering integrin-avβ3 induction on
tumor cells. Furthermore, integrin-avβ3
on tumor cells facilitate the uptake of
viable tumor cells by dendritic cells in
RGD-dependent manner, by which cross-
presentation of immunogenic antigens and
induction of tumor-specific cytotoxic T
lymphocytes are severely compromised at
tumor microenvironments.
7
Overall, these findings provide novel
mechanistic insights whereby cell intrinsic
and environmental regulation of thera-
peutic responses may change the genetic
profiles of tumor cells to activate distinct
sets of DNA damage pathways, causing
the induction of downstream mediators
responsible for modulating tumor micro-
environments and supporting further
tumor progression by compromising endo-
genous host immunity.
Although the molecular machineries
that ATM-mediated DNA damage res-
ponses cause integrin-avβ3 upregulation
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9    9remain unresolved issue, unique genotoxic
stress-induced systems mediated by ATM-
dependent DNA damage signals and NF-
kB-mediated inflammatory cascades, are
required for inducing integrin-avβ3o n
therapy-resistant tumor cells.
7 Consistent
with these findings, previous study
unveiled novel pathways in which ATM
stimulates NFkB-mediated inflammatory
signals in response to genotoxic stimuli
such as cytotoxic drugs and irradiation.
8
Although Ashkenazi et al. recently sug-
gested that acute phase of DNA damage
signals could increase the susceptibility to
apoptotic cell death of Hela cells through
NEMO and TNFa-mediated pathways,
9
the same pathways may in turn contribute
to increased cell survival when chemore-
sistant tumor cells manifest constitutive
activation of ATM and NFkB. Since
NFkB has been established as a critical
sentinel linking inflammation with car-
cinogenic process,
10 chronic activation of
DNA damage responses in tumor cells
may be linked with inflammation-
associated carcinogenesis. Moreover, the
continuous activation of ATM and NFkB
in chemoresistant tumors may be linked
with induction of downstream effectors
responsible for modifying tumor micro-
environments such as integrin-avβ3, and
promoting tumorigenic and metastatic
potential. In these perspectives, we pro-
pose the novel pathways whereby chronic
activation of ATM and NFkB renders
tumor cells with the ability to down-
regulate antitumor immunosurveillance,
at least in part through upregulation of
integrin-avβ3 on tumor cells. In contrast,
acute responses of DNA damage efficiently
eliminate excessively damaged cells by
activating p53-dependent pathways and
antitumor innate immune responses
(Fig.1).
Further elucidation and deep under-
standing of mechanisms linking DNA
damage signals with inflammatory cascades
and their impact on tumor microenviron-
ments should explore new strategy to
target tumors refractory to current anti-
cancer regimens.
Figure1. The dynamics of DNA damage responses in the regulation of tumorigenicity and antitumor immune responses. The activation of DNA damage
pathways has an important role in eliminating tumor cells with excessive DNA replication stresses through coordinated activation of p53 in damaged cell
and NKG2D-dependent innate immune responses. However, under the circumstances where tumor cells are chronically exposed to genotoxic stress
and inflammatory environments, constitutive activation of ATM and NFkB renders tumor cells with the ability to downregulate antitumor
immunosurveillance in part through upregulation of integrin-avb3 on tumor cells and impairment of DC-mediated induction of antitumor CTL.
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